Examination Report |
1 | Authorization Document (POA) | 05 Oct 2017 |
1 | TM-A(TRADE MARKS APPLICATION) | 05 Oct 2017 |
2 | Authorization Document (POA) | 05 Oct 2017 |
2 | TM-A(TRADE MARKS APPLICATION) | 05 Oct 2017 |
3 | Reply to Exam Report (MIS-R) | 14 Feb 2018 |
4 | Reply to Exam Report (MIS-R) | 20 Feb 2018 |
5 | Reply to Exam Report (MIS-R) | 20 Feb 2018 |
6 | Journal Copy | 26 Apr 2018 |
7 | TM-O(NOTICE OF OPPOSITION) | 27 Jun 2018 |
1 | Dispatching of Examination Report for : 3649666 via Email | 5843919 | 2503566 | 07 Feb 2018 |
2 | Opposition Notice | 6905696 | 3145273 | 31 Aug 2018 |
3 | Order Form of 21(2) | 15942049 | 6164347 | 01 Sep 2023 |
Gnformin was applied on 05 October 2017.
Trademark application was filed by GENO PHARMACEUTICALS.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Abandoned.
Listed application Id of Gnformin is 3649666.
Trademark attorney of the Gnformin is Umesh Ghansham Parulkar.
Gnformin is a WORD as per IP India data.